Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New drug approved for the treatment of rheumatoid arthritis

  • Comment

The National Institute for Health and Clinical Excellence has approved tocilizumab (RoActemra) for treating rheumatoid arthritis in patients who have “responded inadequately” to disease modifying anti-rheumatic drugs.

The move updates 2010 guidance and follows an agreement between Roche and the Department of Health which means that the drug will be provided to the NHS at a discount price.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.